Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

5.17
-0.4900-8.66%
Post-market: 5.02-0.1462-2.83%16:57 EDT
Volume:219.63K
Turnover:1.15M
Market Cap:3.98M
PE:-0.28
High:5.69
Open:5.58
Low:4.93
Close:5.66
52wk High:137.96
52wk Low:4.56
Shares:770.10K
Float Shares:533.80K
Volume Ratio:0.02
T/O Rate:41.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.7000
EPS(LYR):-18.7500
ROE:-1888.70%
ROA:-159.56%
PB:-10.88
PE(LYR):-0.28

Loading ...

Jupiter Neurosciences - Royalty of 3% of Net Sales After Third Commercialization Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences - Deal Valued at up to $100 Mln Including Milestone Payments

THOMSON REUTERS
·
Jul 21

Pharmala Licenses Exclusive US Rights to Ala-002 to Jupiter Neurosciences for up to Us$100 Million

Reuters
·
Jul 21

Pharmala Biotech - to Manufacture Gmp-grade Ala-002 for Jupiter Under Separate Supply Agreement

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Development and Regulatory Milestones up to $23.33 Mln Including $20 Mln for FDA Approval

THOMSON REUTERS
·
Jul 21

Pharmala Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to Ala-002

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Upfront Payment of $3.33 Mln: $1.50 Mln Cash, $1.83 Mln in Jupiter Stock

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Deal Valued up to $100 Mln Including $3.33 Mln Upfront and Milestones Plus Royalties

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - to Receive 3% Royalty on U.S. Net Sales After Third Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board

Reuters
·
Jul 07

Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson

THOMSON REUTERS
·
Jul 07

Jupiter Neurosciences Appoints Tomas J. Philipson to Board

Reuters
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 29

Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jun 27

Jupiter Neurosciences Announces Board Member Resignation and Vacancy

TIPRANKS
·
Jun 22

Jupiter Neurosciences director Allison Brady resigns from board, committees

Reuters
·
Jun 22

Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator

Reuters
·
Jun 18

Jupiter Neurosciences Promotes Silva to COO and President

TIPRANKS
·
Jun 06

Jupiter Neurosciences commences patient enrollment in RESET trial

TIPRANKS
·
May 27

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease

THOMSON REUTERS
·
May 27